211 related articles for article (PubMed ID: 36873190)
1. Nanopolyphenol rejuvenates microglial surveillance of multiple misfolded proteins through metabolic reprogramming.
Wang D; Gu X; Ma X; Chen J; Zhang Q; Yu Z; Li J; Hu M; Tan X; Tang Y; Xu J; Xu M; Song Q; Song H; Jiang G; Tang Z; Gao X; Chen H
Acta Pharm Sin B; 2023 Feb; 13(2):834-851. PubMed ID: 36873190
[TBL] [Abstract][Full Text] [Related]
2. A breakdown in microglial metabolic reprogramming causes internalization dysfunction of α-synuclein in a mouse model of Parkinson's disease.
Lu J; Wang C; Cheng X; Wang R; Yan X; He P; Chen H; Yu Z
J Neuroinflammation; 2022 May; 19(1):113. PubMed ID: 35599331
[TBL] [Abstract][Full Text] [Related]
3. Microglial Metabolic Reprogramming: Emerging Insights and Therapeutic Strategies in Neurodegenerative Diseases.
Miao J; Chen L; Pan X; Li L; Zhao B; Lan J
Cell Mol Neurobiol; 2023 Oct; 43(7):3191-3210. PubMed ID: 37341833
[TBL] [Abstract][Full Text] [Related]
4. Targeting microglial autophagic degradation in NLRP3 inflammasome-mediated neurodegenerative diseases.
Wu AG; Zhou XG; Qiao G; Yu L; Tang Y; Yan L; Qiu WQ; Pan R; Yu CL; Law BY; Qin DL; Wu JM
Ageing Res Rev; 2021 Jan; 65():101202. PubMed ID: 33161129
[TBL] [Abstract][Full Text] [Related]
5. p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease.
Chen J; Mao K; Yu H; Wen Y; She H; Zhang H; Liu L; Li M; Li W; Zou F
J Neuroinflammation; 2021 Dec; 18(1):295. PubMed ID: 34930303
[TBL] [Abstract][Full Text] [Related]
6. FcγRIIB mediates the inhibitory effect of aggregated α-synuclein on microglial phagocytosis.
Choi YR; Kang SJ; Kim JM; Lee SJ; Jou I; Joe EH; Park SM
Neurobiol Dis; 2015 Nov; 83():90-9. PubMed ID: 26342897
[TBL] [Abstract][Full Text] [Related]
7. Nanoformulated alpha-mangostin ameliorates Alzheimer's disease neuropathology by elevating LDLR expression and accelerating amyloid-beta clearance.
Yao L; Gu X; Song Q; Wang X; Huang M; Hu M; Hou L; Kang T; Chen J; Chen H; Gao X
J Control Release; 2016 Mar; 226():1-14. PubMed ID: 26836197
[TBL] [Abstract][Full Text] [Related]
8. Microglial autophagy is impaired by prolonged exposure to β-amyloid peptides: evidence from experimental models and Alzheimer's disease patients.
Pomilio C; Gorojod RM; Riudavets M; Vinuesa A; Presa J; Gregosa A; Bentivegna M; Alaimo A; Alcon SP; Sevlever G; Kotler ML; Beauquis J; Saravia F
Geroscience; 2020 Apr; 42(2):613-632. PubMed ID: 31975051
[TBL] [Abstract][Full Text] [Related]
9. Let's make microglia great again in neurodegenerative disorders.
Guillot-Sestier MV; Town T
J Neural Transm (Vienna); 2018 May; 125(5):751-770. PubMed ID: 29027011
[TBL] [Abstract][Full Text] [Related]
10. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
Ciechanover A; Kwon YT
Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
[TBL] [Abstract][Full Text] [Related]
11. Microglial phagocytosis is enhanced by monomeric alpha-synuclein, not aggregated alpha-synuclein: implications for Parkinson's disease.
Park JY; Paik SR; Jou I; Park SM
Glia; 2008 Aug; 56(11):1215-23. PubMed ID: 18449945
[TBL] [Abstract][Full Text] [Related]
12. Distinct microglial response against Alzheimer's amyloid and tau pathologies characterized by P2Y12 receptor.
Maeda J; Minamihisamatsu T; Shimojo M; Zhou X; Ono M; Matsuba Y; Ji B; Ishii H; Ogawa M; Akatsu H; Kaneda D; Hashizume Y; Robinson JL; Lee VM; Saito T; Saido TC; Trojanowski JQ; Zhang MR; Suhara T; Higuchi M; Sahara N
Brain Commun; 2021; 3(1):fcab011. PubMed ID: 33644757
[TBL] [Abstract][Full Text] [Related]
13. A Breakdown in Metabolic Reprogramming Causes Microglia Dysfunction in Alzheimer's Disease.
Baik SH; Kang S; Lee W; Choi H; Chung S; Kim JI; Mook-Jung I
Cell Metab; 2019 Sep; 30(3):493-507.e6. PubMed ID: 31257151
[TBL] [Abstract][Full Text] [Related]
14. Accelerated accumulation of retinal α-synuclein (pSer129) and tau, neuroinflammation, and autophagic dysregulation in a seeded mouse model of Parkinson's disease.
Mammadova N; Summers CM; Kokemuller RD; He Q; Ding S; Baron T; Yu C; Valentine RJ; Sakaguchi DS; Kanthasamy AG; Greenlee JJ; Heather West Greenlee M
Neurobiol Dis; 2019 Jan; 121():1-16. PubMed ID: 30218757
[TBL] [Abstract][Full Text] [Related]
15. Controlled Activation of TRPV1 Channels on Microglia to Boost Their Autophagy for Clearance of Alpha-Synuclein and Enhance Therapy of Parkinson's Disease.
Yuan J; Liu H; Zhang H; Wang T; Zheng Q; Li Z
Adv Mater; 2022 Mar; 34(11):e2108435. PubMed ID: 35023596
[TBL] [Abstract][Full Text] [Related]
16. Increased tauopathy drives microglia-mediated clearance of beta-amyloid.
Chen W; Abud EA; Yeung ST; Lakatos A; Nassi T; Wang J; Blum D; Buée L; Poon WW; Blurton-Jones M
Acta Neuropathol Commun; 2016 Jun; 4(1):63. PubMed ID: 27339073
[TBL] [Abstract][Full Text] [Related]
17. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
[TBL] [Abstract][Full Text] [Related]
18. Honokiol Restores Microglial Phagocytosis by Reversing Metabolic Reprogramming.
Li W; Wang S; Zhang H; Li B; Xu L; Li Y; Kong C; Jiao H; Wang Y; Pang Y; Qin W; Jia L; Jia J
J Alzheimers Dis; 2021; 82(4):1475-1485. PubMed ID: 34151796
[TBL] [Abstract][Full Text] [Related]
19. α-mangostin derivative 4e as a PDE4 inhibitor promote proteasomal degradation of alpha-synuclein in Parkinson's disease models through PKA activation.
Chen JY; Zhu Q; Cai CZ; Luo HB; Lu JH
Phytomedicine; 2022 Jul; 101():154125. PubMed ID: 35525236
[TBL] [Abstract][Full Text] [Related]
20. Microglial activation and its implications in the brain diseases.
Dheen ST; Kaur C; Ling EA
Curr Med Chem; 2007; 14(11):1189-97. PubMed ID: 17504139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]